文献速递瓣膜病与结构性心脏病

小瓣环女性TAVI:SMART随机试验中瓣膜类型的比较

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2024-01-01

SMART试验预设二次分析纳入621例小瓣环女性,随机接受自膨胀瓣膜(SEV)或球囊扩张瓣膜(BEV)。

要点

  • 小瓣环女性TAVI后12个月SEV与BEV临床复合终点无显著差异。
  • SEV组生物瓣功能障碍发生率显著低于BEV组(8.4% vs 41.8%)。
  • SEV组跨瓣压差更低、有效瓣口面积更大、瓣周漏更少。

核心结论

  • 小瓣环女性TAVI使用SEV与BEV的12个月临床复合终点相似,但SEV显著降低生物瓣功能障碍和患者-人工瓣膜不匹配,并改善生活质量。

研究设计与样本

  • 本报告为预设二次分析,纳入SMART中全部621例女性(平均年龄80.2岁,SEV组312例,BEV组309例)。

主要发现

  • SEV组30天和12个月主动脉瓣跨瓣压差更低、有效瓣口面积更大,12个月轻度及以上主动脉瓣反流更少。
  • 无论采用何种定义及是否校正体重指数,SEV组患者-人工瓣膜不匹配均显著更低。
  • SEV组在VARC-3序数生活质量量表评估中表现更优。

临床怎么用

  • 对于小瓣环女性重度症状性主动脉瓣狭窄行TAVI,SEV与BEV临床结局相似,但SEV在瓣膜功能和患者-人工瓣膜不匹配方面更优。
  • 选择瓣膜类型时可结合瓣膜耐久性、血流动力学和生活质量获益,个体化考虑SEV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Historically, women with aortic stenosis have experienced worse outcomes and inadequate recognition compared to men, being both underdiagnosed and undertreated, while also facing underrepresentation in clinical trials. OBJECTIVE: To determine whether women with small aortic annuli undergoing transcatheter aortic valve replacement have better clinical and hemodynamic outcomes with a self-expanding valve (SEV) or balloon-expandable valve (BEV). DESIGN, SETTING, PARTICIPANTS: The Small Annuli Randomized to Evolut or SAPIEN Trial (SMART) was a large-scale randomized clinical trial focusing on patients with small aortic annuli undergoing transcatheter aortic valve replacement, randomized to receive SEVs or BEVs and included 716 patients treated at 83 centers in Canada, Europe, Israel, and the US from April 2021 to October 2022. This prespecified secondary analysis reports clinical and hemodynamic findings for all 621 women enrolled in SMART. Data for this report were analyzed from February to April 2024. INTERVENTIONS: Transcatheter aortic valve replacement with an SEV or a BEV. MAIN OUTCOMES AND MEASURES: The composite coprimary clinical end point comprised death, disabling stroke, or heart failure-related rehospitalization. The coprimary valve function end point was the incidence of bioprosthetic valve dysfunction, both assessed through 12 months. Secondary end points included the incidence of moderate or severe prosthesis-patient mismatch. RESULTS: A total of 621 women (mean [SD] age, 80.2 [6.2] years; 312 randomized to the SEV group and 309 to the BEV group) were included in the present analysis. At 12 months, there were no significant differences in the coprimary clinical end point between the SEV and BEV groups (9.4% vs 11.8%, absolute risk difference -2.3%; 95% CI -7.2 to 2.5, P = .35). However, SEV implantation was associated with less bioprosthetic valve dysfunction (8.4% vs 41.8%; absolute risk difference, -33.4%; 95% CI, -40.4 to -26.4; P < .001). SEV implantation resulted in lower aortic valve gradients and larger effective orifice areas at 30 days and 12 months and less mild or greater aortic regurgitation at 12 months compared to BEV implantation. Prosthesis-patient mismatch was significantly lower with SEVs, regardless of the definition used and adjustment for body mass index. Use of SEVs was associated with better quality of life outcomes as assessed by the Valve Academic Research Consortium-3 ordinal quality of life measure. CONCLUSIONS AND RELEVANCE: Among women with severe symptomatic aortic stenosis and small aortic annuli undergoing transcatheter aortic valve replacement, the use of SEVs, compared to BEVs, resulted in similar clinical outcomes and a markedly reduced incidence of bioprosthetic valve dysfunction through 12 months, including a lower risk of prosthesis-patient mismatch and better 12-month quality of life. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04722250.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Tchétché D, Mehran R, Blackman DJ, et al. Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 39382856. doi:10.1001/jamacardio.2024.3241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。